Zhihui Liu

Title: Innovations of Zhihui Liu in Pharmaceutical Formulation

Introduction

Zhihui Liu is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceutical formulation, particularly in the development of injectable medications. His work focuses on improving the stability and efficacy of drug formulations, which is crucial for patient treatment.

Latest Patents

Zhihui Liu holds 1 patent for his invention titled "Aripiprazole injectable suspension formulation having prolonged shelf life." This innovative formulation addresses the challenges associated with the shelf life of aripiprazole, a medication used to treat schizophrenia and related disorders. The patent outlines methods for enhancing the stability of the injectable suspension, ensuring that it remains effective for a longer period.

Career Highlights

Zhihui Liu is associated with Nanjing Noratech Pharmaceuticals Co., Ltd., where he applies his expertise in pharmaceutical development. His work at the company has been instrumental in advancing drug formulations that meet the needs of patients and healthcare providers.

Collaborations

Zhihui Liu collaborates with talented professionals in his field, including Yunzhe Sun and Qi Peng. These collaborations enhance the research and development efforts at Nanjing Noratech Pharmaceuticals Co., Ltd., leading to innovative solutions in pharmaceutical formulations.

Conclusion

Zhihui Liu's contributions to pharmaceutical formulation, particularly through his patented work on aripiprazole, highlight his role as an influential inventor in the industry. His dedication to improving drug stability and efficacy continues to impact the treatment of schizophrenia and related diseases.